|
MedPlus Health Services Limited (MEDPLUS.NS) DCF Valuation
IN | Healthcare | Medical - Pharmaceuticals | NSE
|
- ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
- ✓ Professional Design: Trusted, Industry-Standard Templates
- ✓ Pre-Built For Quick And Efficient Use
- ✓ No Expertise Is Needed; Easy To Follow
MedPlus Health Services Limited (MEDPLUS.NS) Bundle
Enhance your investment strategies with the (MEDPLUSNS) DCF Calculator! Explore authentic MedPlus Health Services Limited financials, adjust growth projections and expenses, and instantly observe how these changes influence the intrinsic value of (MEDPLUSNS).
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 28,512.5 | 30,507.8 | 37,553.8 | 45,575.8 | 56,248.6 | 66,777.2 | 79,276.7 | 94,115.8 | 111,732.6 | 132,646.9 |
| Revenue Growth, % | 0 | 7 | 23.1 | 21.36 | 23.42 | 18.72 | 18.72 | 18.72 | 18.72 | 18.72 |
| EBITDA | 1,509.6 | 2,382.1 | 3,037.3 | 3,117.5 | 3,940.9 | 4,679.4 | 5,555.3 | 6,595.1 | 7,829.6 | 9,295.1 |
| EBITDA, % | 5.29 | 7.81 | 8.09 | 6.84 | 7.01 | 7.01 | 7.01 | 7.01 | 7.01 | 7.01 |
| Depreciation | 748.1 | 882.7 | 1,193.6 | 1,815.6 | 2,242.1 | 2,225.7 | 2,642.3 | 3,136.9 | 3,724.1 | 4,421.2 |
| Depreciation, % | 2.62 | 2.89 | 3.18 | 3.98 | 3.99 | 3.33 | 3.33 | 3.33 | 3.33 | 3.33 |
| EBIT | 761.6 | 1,499.4 | 1,843.7 | 1,301.9 | 1,698.8 | 2,453.7 | 2,912.9 | 3,458.2 | 4,105.5 | 4,874.0 |
| EBIT, % | 2.67 | 4.91 | 4.91 | 2.86 | 3.02 | 3.67 | 3.67 | 3.67 | 3.67 | 3.67 |
| Total Cash | 1,409.5 | 1,491.3 | 6,575.7 | 2,961.3 | 1,650.4 | 4,911.3 | 5,830.6 | 6,921.9 | 8,217.6 | 9,755.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 286.9 | 108.3 | 362.4 | 86.5 | 175.0 | 377.6 | 448.3 | 532.2 | 631.8 | 750.0 |
| Account Receivables, % | 1.01 | 0.35489 | 0.96496 | 0.18982 | 0.31119 | 0.56545 | 0.56545 | 0.56545 | 0.56545 | 0.56545 |
| Inventories | 6,435.6 | 7,499.6 | 9,149.8 | 11,440.9 | 13,402.3 | 16,086.4 | 19,097.5 | 22,672.1 | 26,916.0 | 31,954.1 |
| Inventories, % | 22.57 | 24.58 | 24.36 | 25.1 | 23.83 | 24.09 | 24.09 | 24.09 | 24.09 | 24.09 |
| Accounts Payable | 2,341.5 | 1,480.9 | 2,462.3 | 2,601.4 | 2,530.4 | 3,983.9 | 4,729.6 | 5,614.9 | 6,665.9 | 7,913.6 |
| Accounts Payable, % | 8.21 | 4.85 | 6.56 | 5.71 | 4.5 | 5.97 | 5.97 | 5.97 | 5.97 | 5.97 |
| Capital Expenditure | -302.1 | -542.6 | -1,177.2 | -1,690.1 | -844.0 | -1,493.3 | -1,772.9 | -2,104.7 | -2,498.7 | -2,966.4 |
| Capital Expenditure, % | -1.06 | -1.78 | -3.13 | -3.71 | -1.5 | -2.24 | -2.24 | -2.24 | -2.24 | -2.24 |
| Tax Rate, % | 10.85 | 10.85 | 10.85 | 10.85 | 10.85 | 10.85 | 10.85 | 10.85 | 10.85 | 10.85 |
| EBITAT | 56.5 | 1,006.9 | 1,497.6 | 1,373.7 | 1,514.4 | 1,692.8 | 2,009.6 | 2,385.8 | 2,832.4 | 3,362.6 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -3,878.5 | -398.9 | 591.0 | -376.9 | 791.5 | 992.1 | 543.1 | 644.7 | 765.4 | 908.6 |
| WACC, % | 6.79 | 7.37 | 7.51 | 7.69 | 7.59 | 7.39 | 7.39 | 7.39 | 7.39 | 7.39 |
| PV UFCF | ||||||||||
| SUM PV UFCF | 3,126.9 | |||||||||
| Long Term Growth Rate, % | 4.00 | |||||||||
| Free cash flow (T + 1) | 945 | |||||||||
| Terminal Value | 27,876 | |||||||||
| Present Terminal Value | 19,517 | |||||||||
| Enterprise Value | 22,643 | |||||||||
| Net Debt | 9,184 | |||||||||
| Equity Value | 13,460 | |||||||||
| Diluted Shares Outstanding, MM | 120 | |||||||||
| Equity Value Per Share | 112.14 |
What You Will Receive
- Flexible Forecast Inputs: Effortlessly adjust key parameters (growth %, profit margins, WACC) to generate various scenarios.
- Realistic Financial Data: MedPlus Health Services Limited’s financial information pre-loaded to enhance your analysis.
- Automated DCF Calculations: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional Design: A sophisticated Excel model tailored to suit your valuation requirements.
- Designed for Analysts and Investors: Perfect for assessing projections, validating approaches, and optimizing your time.
Key Features
- Comprehensive DCF Calculator: Features both unlevered and levered DCF valuation models tailored for MedPlus Health Services Limited (MEDPLUSNS).
- WACC Calculation Tool: A pre-configured Weighted Average Cost of Capital sheet with adjustable parameters.
- Customizable Forecast Inputs: Easily modify assumptions for growth rates, capital expenditures, and discount rates.
- Integrated Financial Ratios: Evaluate profitability, leverage, and operational efficiency ratios specific to MedPlus Health Services Limited (MEDPLUSNS).
- Interactive Dashboard and Visualizations: Graphical representations provide a clear overview of key valuation metrics for straightforward analysis.
How It Works
- Step 1: Download the prebuilt Excel template featuring data on MedPlus Health Services Limited (MEDPLUSNS).
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with key metrics.
- Step 3: Adjust forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly view updated results, including the intrinsic value of MedPlus Health Services Limited (MEDPLUSNS).
- Step 5: Utilize the outputs to make informed investment decisions or generate detailed reports.
Why Choose This Calculator for MedPlus Health Services Limited (MEDPLUSNS)?
- Reliable Data: Up-to-date MedPlus financials provide trustworthy valuation outcomes.
- Flexible Options: Tailor essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
- Efficient: Ready-made calculations save you the hassle of starting with a blank slate.
- Professional Quality: Crafted for the needs of investors, analysts, and advisors.
- User-Friendly: Simple layout and guided instructions ensure accessibility for all users.
Who Should Use MedPlus Health Services Limited (MEDPLUSNS)?
- Investors: Assess the fair value of MedPlus Health Services Limited (MEDPLUSNS) to inform investment choices.
- CFOs: Utilize a sophisticated DCF model for precise financial reporting and analysis.
- Consultants: Efficiently customize the valuation template for client reports.
- Entrepreneurs: Learn from the financial modeling practices of leading companies in the healthcare sector.
- Educators: Employ it as a resource for teaching valuation techniques in finance courses.
What the Template Includes
- Preloaded MEDPLUSNS Data: Historical and projected financial metrics, such as revenue, EBIT, and capital expenditures.
- DCF and WACC Models: High-quality spreadsheets designed for computing intrinsic value and Weighted Average Cost of Capital.
- Adjustable Inputs: Cells highlighted in yellow for modifying revenue growth rates, tax percentages, and discount rates.
- Financial Statements: Detailed annual and quarterly financial reports for in-depth analysis.
- Key Ratios: Analysis of profitability, leverage, and efficiency ratios to assess overall performance.
- Dashboard and Charts: Visual representations of valuation results and underlying assumptions.
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.